Ajooni Biotech Q2 FY26 results: PAT up, revenue grows for half year

Revenue growth above 20%Profit growth above 25%EBITDA margin expansionResults View source PDF Explain this filing

AJOONI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.6%Reaction day

₹5.00

prior close

₹4.97

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.1%+2.7% vs market

Food Products peers, median of 85sector · industry level-0.4%+3.0% vs sector

On the reaction day the stock moved 2.7 pts more than Nifty Microcap 250 and 3.0 pts more than its Food Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.6

30m

+5.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.6-0.1+2.7-0.4+3.0

Next day

+2.8-0.2+3.0-0.5+3.3

+0.8+0.4+0.4-0.9+1.7

-1.4-0.4-1.0-1.0-0.4

-6.0-0.6-5.4-1.1-4.9

-3.2-0.9-2.3-2.2-1.0

-8.2-3.0-5.2-4.0-4.2

15d

-7.8-3.9-3.9-5.5-2.3

-10.4-4.8-5.6-5.9-4.5

-17.8-7.8-10.0-9.0-8.8

-1.0-7.2+6.2-11.2+10.2

UpDownMarket · Nifty Microcap 250Sector · Food Products peers, median of 85Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Ajooni Biotech reported Q2 FY26 revenue from operations of 3,173.51 lakh against 3,126.77 lakh YoY and net profit of 93.21 lakh against 78.14 lakh. For H1 FY26, revenue grew about 23 percent to 6,300.28 lakh and PAT rose about 58 percent to 171.35 lakh. Quarterly EPS stood at 0.08. The board approved the unaudited results and limited review report on November 13, 2025. Cash and equivalents rose sharply to 1,528.70 lakh from 683.02 lakh.

Likely market impact

Healthy H1 performance with revenue up about 23 percent and PAT up about 58 percent YoY. Improved cash position supports growth investments.